How did GEHC's Q4 earnings compare to forecasts?

GE HealthCare's (GEHC) Q4 earnings exceeded forecasts in terms of EPS, with the company reporting a diluted EPS of $1.57, compared to the forecasted $1.06. This indicates a significant year-over-year increase, as the EPS in the same period last year was $0.88. The revenue performance also surpassed expectations, with GEHC achieving revenue of $5.3 billion, surpassing the estimated $4.86 billion. This represents a 2% year-over-year growth, driven by strong performances in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The organic revenue growth, which excludes the impact of acquisitions, was also positive, contributing to the overall revenue outperformance.